Plastic is an essential component in medical applications and can be used to optimize asepsis rules and develop new treatments for diseases. It is found everywhere: in materials, equipment, clothing, floor and wall coverings etc.
Disposable medical materials, such as syringes, vials, catheters, liquid pouches etc. help to prevent the risk of infection.
In the field of substitutive medicine, in which diseased organs are replaced by artificial organs, it is one of the materials ideally guaranteeing compatibility with the human body.
With excellent mechanical and chemical qualities, and considerable stability over time, biomaterials are used in orthopedics or for the reconstruction of damaged tendons for example.
Laboratories around the world are exploring applications of plastics-derived microsystems and nanotechnologies. In the future, nanopolymers will be used in treatments to transport active substances directly to damaged cells.
Set up in July 2005, Plastipolis is the only plastics processing competitiveness cluster in France. It brings together the players in this sector in the Franche-Comté and Rhône-Alpes regions where 30% of France’s plastics industry is concentrated, generating €8 billion of turnover and making it the second-largest plastics processing region in Europe.
The boundaries of the Plastipolis cluster thus extend from the south of the Jura region to the north of the Ardèche, and include Plastics Valley, the birthplace of the French plastics industry. In figures, the industry employs 33,000 people and includes 1,000 companies, i.e. 20% of all plastics processing jobs and companies in France.
The Plastipolis competitiveness cluster is developing a strategy that directs companies towards new markets characterized by technological innovation using micro and nanostructuring of polymers.
With 38% of all French researchers in the plastics processing sector, the Plastipolis cluster coordinates innovative projects based around 4 high-tech areas: materials and compounds, procedures and tooling, composite materials and nanotechnologies. It works to promote two areas of technology integration: eco-plastics processing and smart products.
COMIPOL BAC: Thin-film antibacterial polymers
Objectives:
• Prevent the adhesion of bacteria
• Prevent the development and proliferation of bacteria on a surface
• Reduce bacterial contamination risk of a surface through application of a "metallic oxide" antibacterial thin film
Project partners: GERFLOR, CIAT, R&D Industrie, NOSOCOTECH , CIRIMAT et le CEA de Grenoble.
Innovation project to improve injection safety
"Pic" concept:
Development of an innovative device to automatically make medical injection needles safe.
Objective:
To design a pilot workshop model measuring 1 m² that is industrially reproducible using precision engineering with the active support of the French National Engineering Institute in Mechanics and Microtechnology, so that each licensee of the "Pic" will be provided with a tool placed at the end of the production line to cap standard commercial needles with a "SpringCap" or "SpringLok" safety device supplied by our outstanding industrial partners.
Project partners: BIO FRONT, ENSMM, SAINT-GOBAIN PPL France.
 | A Skin Ageing Diagnosis Centre unique in France |
 | Zimmer : quality and traceability |
 | DIXI Microtechniques designs and manufactures electrodes for use in neurosurgery |
 | Micro-Mega – a century in Besançon |
 | Uyghur medicine: cooperation between France, China and Thailand |
 | Besançon: a new cellular therapy product! |
 | Artechnic: a mobile distribution device |
 | Technological performance: FEMTO-ST and micro-assembly |
 | Biomedical engineering: FEMTO-ST and in-vitro fertilization |
| A framework agreement between Besançon and Dijon will create a vast hospital complex in the southern half of Eastern France |
